UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

Molecular cancer, 2012-04, Vol.11 (1), p.25-25, Article 25

2012

Volltextzugriff (PDF)

Identification of a biomarker panel for colorectal cancer diagnosis

BMC cancer, 2012-01, Vol.12 (1), p.43-43, Article 43

2012

Volltextzugriff (PDF)

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

The New England journal of medicine, 2009-09, Vol.361 (10), p.958-967

2009

Volltextzugriff (PDF)

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

The lancet oncology, 2013-09, Vol.14 (10), p.962-970

2013

Volltextzugriff (PDF)

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2747-2754

2007

Volltextzugriff (PDF)

Immunogenicity of COVID-19 vaccines in lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2023-10, Vol.184, p.107323-107323, Article 107323

2023

Volltextzugriff (PDF)

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

Cancer chemotherapy and pharmacology, 2021-04, Vol.87 (4), p.543-553

2021

Volltextzugriff (PDF)

Hereditary pancreatic cancer: related syndromes and clinical perspective

Hereditary cancer in clinical practice, 2017-06, Vol.15 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Scientific reports, 2015-12, Vol.5 (1), p.17499, Article 17499

2015

Volltextzugriff (PDF)

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression

PloS one, 2009-05, Vol.4 (5), p.e5133-e5133

2009

Volltextzugriff (PDF)

A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis

Journal of thoracic oncology, 2014-10, Vol.9 (10), p.1504-1512

2014

Volltextzugriff (PDF)

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8509-8509

2019

Volltextzugriff (PDF)

Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

PloS one, 2014-10, Vol.9 (10), p.e109659-e109659

2014

Volltextzugriff (PDF)

Just an Acute Pulmonary Edema? Paraneoplastic Thyroid Storm Due to Invasive Mole

Case reports in oncology, 2022-05, Vol.15 (2), p.566-572

2022

Volltextzugriff (PDF)

Thymidylate synthase expression determines pemetrexed targets and resistance development in tumour cells

PloS one, 2013-05, Vol.8 (5), p.e63338

2013

Volltextzugriff (PDF)

Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): a case report

Hereditary cancer in clinical practice, 2019-08, Vol.17 (1), p.23-6, Article 23

2019

Volltextzugriff (PDF)

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study

Translational lung cancer research, 2022-01, Vol.11 (1), p.53-63

2022

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(55)
Humans
(52)
Oncology
(49)
Female
(35)
Male
(35)
Middle Aged
(32)
Aged
(24)
Adult
(20)
Lung Cancer
(19)
Chemotherapy
(17)
Lung Neoplasms - Drug Therapy
(16)
Treatment Outcome
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(14)
Survival Analysis
(13)
Tumors
(13)
Cancer Therapies
(12)
Cisplatin - Administration & Dosage
(12)
Patients
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

Identification of a biomarker panel for colorectal cancer diagnosis

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

Immunogenicity of COVID-19 vaccines in lung cancer patients

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

Hereditary pancreatic cancer: related syndromes and clinical perspective

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression

A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment

Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

Just an Acute Pulmonary Edema? Paraneoplastic Thyroid Storm Due to Invasive Mole

Thymidylate synthase expression determines pemetrexed targets and resistance development in tumour cells

Germline c.1A>C heterozygous pathogenic variant in SDHA reported for the first time in a young adult with a gastric gastrointestinal stromal tumour (GIST): a case report

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile

Suchergebnisse filtern